Kymos Group celebrates 25 years #SupportingScience
Official Press Release Kymos Group, a European CRO & CLO [...]
USP <665>/<1665>: Extractables & Leachables in Single-Use-Systems
Single-use systems (SUS) have become an integral part of modern [...]
Biosimilar Development: From Phase III to Analytical Comparability and PK/PD
Although the development of biosimilars has historically been difficult, expensive, [...]
OligoXplorer: Our CMC Platform for Oligonucleotide Therapeutics
Oligonucleotide-based therapeutics have become one of the most promising [...]